Journal of Food Science & Nutrition Category: Agriculture Type: Review Article

Malnutrition and Hypoglycemia Risk among Patients with Diabetes Mellitus

Khanimov I1, Wainstein J2, Shimonov M3 and Leibovitz E4*
1 Sackler school of medicine, Tel Aviv University, Tel Aviv, Israel
2 Sackler school of medicine, Diabetes Unit, Wolfson Medical Center, Tel Aviv University, Tel Aviv, Holon, Israel
3 Department of surgery a, Sackler School of Medicine, E. Wolfson Medical Center, Tel Aviv University, Tel Aviv, Holon, Israel
4 Department of internal medicine a, Yoseftal Hospital, Eilat, Israel

*Corresponding Author(s):
Leibovitz E
Department Of Internal Medicine A, Yoseftal Hospital, Eilat, Israel
Tel:972 35028624,

Received Date: Mar 11, 2019
Accepted Date: Mar 29, 2019
Published Date: Apr 08, 2019


Hypoglycemia is associated with increased risk of morbidity and mortality, and is detrimental to patients regardless of Diabetes Mellitus (DM) status. Among patients with DM, hypoglycemia is considered a result of overtreatment of anti-diabetic agents (iatrogenic hypoglycemia). Among patients without DM, this condition is attributed to disease severity. Recently, high malnutrition risks, as well as other markers of malnutrition, were indicative of increased risk of hypoglycemia among hospitalized patients. In this review we focus on the relationship between hypoglycemia and malnutrition among patients with and without DM.


Albumin; Diabetes mellitus; Hypoglycemia; Malnutrition; Nutrition


Hypoglycemia can be defined as serum glucose level equal or under 70mg/dL (≤ 3.9mmol/L) [1,2]. Among patients with diabetes mellitus, and in accordance with the International Hypoglycemia Study Group guidelines, serum glucose under 54mg/dL (≤3.0mmol/L), is sufficiently low to indicate serious, clinically important hypoglycemia and thus should be routinely reported in clinical trials dealing with glucose-lowering agents [3]. For decades, it was assumed that serum glucose level is mostly regulated by two hormones-insulin and glucagon. Nowadays, it is well known that glucose homeostasis is regulated by various glucoregulatory hormones which effect multiple target tissues, such as muscle, brain, liver, and adipocyte [4,5].

Classification of hypoglycemia

According to the report of the workgroup of the American Diabetes Association and The Endocrine Society, hypoglycemia can be classified as follows [6].

Severe hypoglycemia

Severe hypoglycemia is an event requiring assistance of another person to actively administer carbohydrates, glucagon, or take other corrective actions. Plasma glucose concentrations may not be available during an event, but neurological recovery following the return of plasma glucose to normal is considered sufficient evidence that the event was induced by a low plasma glucose concentration.

Documented symptomatic hypoglycemia

Documented symptomatic hypoglycemia is an event during which typical symptoms of hypoglycemia are accompanied by a measured plasma glucose concentration ≤70mg/dL (≤3.9mmol/L).

Asymptomatic hypoglycemia

Asymptomatic hypoglycemia is an event not accompanied by typical symptoms of hypoglycemia but with a measured plasma glucose concentration ≤70mg/dL (≤3.9mmol/L).

Probable symptomatic hypoglycemia

Probable symptomatic hypoglycemia is an event during which symptoms typical of hypoglycemia are not accompanied by a plasma glucose determination but that was presumably caused by a plasma glucose concentration ≤70mg/dL (≤3.9mmol/L).


Pseudo-hypoglycemia is an event during which the person with diabetes reports any of the typical symptoms of hypoglycemia with a measured plasma glucose concentration >70mg/dL (>3.9mmol/L) but approaching that level.

*According to the previous report of the American Diabetes Association workgroup on hypoglycemia from 2004, this state was defined as “Relative hypoglycemia” [7].

Risk factors and prognosis associated with hypoglycemia

Risk factors for hypoglycemia among hospitalized patients include DM, older age, disease severity, renal insufficiency, septic shock, mechanical ventilation, tight glycemic control and increasing number of anti diabetic agents [8,9]. Iatrogenic hypoglycemia is associated with administration of insulin and insulin-secretagogues (sulfonylureas and meglitinides) [10].

Documented hypoglycemia is associated with poor short and long term prognosis among patients admitted to internal medicine departments regardless of Diabetes Mellitus (DM) status [11]. Among patients with DM, hypoglycemia was repeatedly shown to be associated with an increased length of hospital stay and decreased short and long term survival [9,11-13]. Moreover, hypoglycemia was found to be associated with an increased risk for dementia among older adults with DM [14-16]. Association between morbidity and hypoglycemia among patients without DM was documented as well [17-19]. While the prevalence of hypoglycemia is higher among DM patients, the prognosis of patients with hypoglycemia is worse among patients without DM [20]. This raises the possibility that the etiology of hypoglycemia, rather than hypoglycemia per-se, is responsible for the poor outcome observed.

Spontaneous hypoglycemia

As described previously, hypoglycemia can also occur among hospitalized patients without DM. Unexpected severe (below 55mg/dL, 3mmol/L) hypoglycemia in non-diabetic patients outside the intensive care unit was 36 per 10,000 admissions (95% CI 24-64), and more than 90% of the patients were admitted as emergency cases [21]. Rate of hypoglycemia was higher among patients aged 65 and over. Hypoglycemia was more prevalent among patients with sepsis, kidney disease, alcohol dependence, pneumonia, liver disease, cancer, and self-harm with hypoglycemic agents. Spontaneous hypoglycemia may also occur among patients with DM, as was found among patients suffering from infection, with or without sepsis [22]. Postprandial (reactive) hypoglycemia may also be the cause of spontaneous hypoglycemia among patients with DM [23,24].

Hypoglycemia and malnutrition

Malnutrition is defined as an imbalance between consumption and expenditure of either energy, protein or any other nutrient that damages body function [25].

Several suggestions for classification of malnutrition were suggested over the years, mostly in infants and children in developing countries. In 1955, Gomez et al. [26], suggested a classification of malnutrition in infancy and childhood based on child's weight compared to that of a child in the 50th percentile of the same age. A later classification by Waterlow et al. [27], was based on z- Scores (SD) which took into account both weight and height of the child. The World Health Organization (WHO) classification is based on Waterlow’s system with some modifications [28].

Two major clinical syndromes of malnutrition include kwashiorkor (almost normal weight for age, marked generalized edema) and marasmus (depletion of subcutaneous fat stores, muscle wasting, and absence of edema), though a mixed variant is also frequent [28].

Several types of malnutrition were described with different pathogeneses [29]. For example, malnutrition can be induced by reduced food intake due to diminished appetite, or as a result of impaired nutrient absorption [30]. Other causes include older age, socio-economic status and comorbidities [31]. In 2015, about 795 million people were undernourished worldwide [32]. Prevalence of malnutrition is high among inpatients as well. In a study including 504 newly hospitalized adult patients, 159 of them (31.5%) were identified as being at high risk for malnutrition according to the Nutrition Risk Score (NRS) 2002 [33,34]. Other studies showed that as many as 50% of all patients admitted to hospitals in western countries were malnourished or had an increased risk of malnutrition [35,36].

In the developing world, it has been demonstrated that patients with severe malnutrition (and hypoglycemia) may have Malnutrition-Related Diabetes Mellitus (MRDM), a rare type of diabetes associated with long term malnutrition [37,38]. Additionally, we showed recently that one of the risk factors for hypoglycemia among patients with and without DM was high risk for malnutrition as measured by the NRS2002 [39]. 

There are several surrogate markers for malnutrition that can be measured in the blood stream, serum albumin being the most frequently used. Albumin level was shown to be influenced by nutritional status [40], however, there is still a controversy whether albumin level is a marker of nutrition status [41], because it plays a major role in various medical conditions [42]. Interestingly, serum albumin is as accurate a predictor of outcome as the APACHE II Score among Intensive Care Unit (ICU) patients [43]. Low albumin level is associated with increased morbidity and mortality in many patient populations [44,45]. 

Other marker suggested as an indicator of malnutrition is serum prealbumin (i.e transthyretin). The major source of this protein is in the liver [46] and it has a half-life of two days [47]. Moreover, serum level of prealbumin is not altered by hydration status [48]. A reverse correlation was found between prealbumin level and mortality among hospitalized elderly patients with a decreased nutrient intake [49] and patients treated with hemodialysis and peritoneal dialysis [50]. On the other hand, among critically ill patients with inflammation, serum prealbumin level was not a sensitive marker for evaluating the adequacy of nutrition support. It was found that only change in CRP level was able to significantly predict changes in level of prealbumin, indicating that increase in prealbumin was as a result of improvement in inflammation, rather than nutrient intake [51].

Additional markers of nutritional status include serum cholesterol. It was shown that among patients with DM, both total and LDL cholesterol levels were lower in undernourished patients compared to well-nourished [52]. This was true regardless of treatment with insulin. In a recently published systematic review and meta-analysis regarding the association between blood biomarkers and risk of malnutrition in older adults, it was found that serum albumin, prealbumin and total cholesterol are useful biochemical indicators of malnutrition, even with the presence of chronic inflammation [53]. Recently we showed that serum albumin and cholesterol levels measured at hospital admission, predict hypoglycemia in patients admitted to general internal medicine units, regardless of DM status [54].

The mechanism responsible for hypoglycemia among malnourished patients is still unknown. A possible explanation might be a depletion of hepatic glycogen storage. Evidence to support the association of glycogen storage with hypoglycemia can be found in patients that suffer from Glycogen Storage Disorders (GSDs). These disorders are inborn errors of metabolism with abnormal storage or utilization of glycogen, with a cardinal presenting feature of hypoglycemia [55]. In spite of the different pathophysiology of both conditions, they may have the same clinical outcome, i.e., hypoglycemia. Other factors that may increase the likelihood of glycogen depletion include a shift towards anaerobic metabolism. Further research is warranted to determine the pathophysiology of hypoglycemia among malnourished patients.


In conclusion, hypoglycemia is associated with poor short and long-term prognosis and increased morbidity and mortality. Hypoglycemia is more common among patients with DM, probably as a result of anti-diabetic agents. However, it can occur among patients without DM as well. After diagnosis of hypoglycemia is established, a thorough evaluation of patient's nutritional status is recommended because of high risk for malnutrition. This is true regardless of DM status. We recommend that nutritional assessment includes both laboratory tests as well as a referral to nutrition nurse, dietitian or expert clinician for further evaluation, including nutrition risk screening questionnaire and other nutritional and metabolic variables. A detailed care plan should be established following careful monitoring of outcomes.


All the authors declare no conflict of interest.


  1. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, et al. (2013) Hypoglycemia and diabetes: A report of a workgroup of the American Diabetes Association and The Endocrine Society. J Clin Endocrinol Metab 98: 1845-1859.
  2. Cryer PE (2009) Preventing hypoglycaemia: What is the appropriate glucose alert value? Diabetologia 52: 35-37.
  3. International Hypoglycaemia Study Group (2017) Glucose concentrations of less than 3.0mmol/L (54mg/dL) should be reported in clinical trials: A joint position statement of the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care 40: 155-157.
  4. Wasserman DH (2009) Four grams of glucose. Am J Physiol Endocrinol Metab 296: 11-21.
  5. Aronoff SL, Berkowitz K, Shreiner B, Want L (2004) Glucose metabolism and regulation: Beyond insulin and glucagon. Diabetes Spectr 17: 183-190.
  6. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, et al. (2013) Hypoglycemia and diabetes: A report of a workgroup of the American Diabetes Association and The Endocrine Society. Diabetes Care 36: 1384-1395.
  7. Workgroup on Hypoglycemia, American Diabetes Association (2005) Defining and reporting hypoglycemia in diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 28: 1245-1249.
  8. Krinsley JS, Grover A (2007) Severe hypoglycemia in critically ill patients: Risk factors and outcomes. Crit Care Med 35: 2262-2267.
  9. Boucai L, Southern WN, Zonszein J (2011) Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. Am J Med 124: 1028-1035.
  10. Bonaventura A, Montecucco F, Dallegri F (2015) Update on strategies limiting iatrogenic hypoglycemia. Endocr Connect 4: 37-45.
  11. Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, et al. (2009) Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care 32: 1153-1157.
  12. Zapatero A, Gómez-Huelgas R, González N, Canora J, Asenjo A, et al. (2014) Frequency of hypoglycemia and its impact on length of stay, mortality, and short-term readmission in patients with diabetes hospitalized in internal medicine wards. Endocr Pract 20: 870-875.
  13. Brodovicz KG, Mehta V, Zhang Q, Zhao C, Davies MJ, et al. (2013) Association between hypoglycemia and inpatient mortality and length of hospital stay in hospitalized, insulin-treated patients. Curr Med Res Opin 29: 101-107.
  14. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP, Selby JV (2009) Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301: 1565-1572.
  15. Chaytor NS, Barbosa-Leiker C, Ryan CM, Germine LT, Hirsch IB, et al. (2019) Clinically significant cognitive impairment in older adults with type 1 diabetes. J Diabetes Complications 33: 91-97.
  16. Yaffe K, Falvey CM, Hamilton N, Harris TB, Simonsick EM, et al. (2013) Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 173: 1300-1306.
  17. Fischer KF, Lees JA, Newman JH (1986) Hypoglycemia in hospitalized patients. Causes and outcomes. N Engl J Med 315: 1245-1250.
  18. Mannucci E, Monami M, Mannucci M, Chiasserini V, Nicoletti P, et al. (2006) Incidence and prognostic significance of hypoglycemia in hospitalized non-diabetic elderly patients. Aging Clin Exp Res 18: 446-451.
  19. Shilo S, Berezovsky S, Friedlander Y, Sonnenblick M (1998) Hypoglycemia in hospitalized nondiabetic older patients. J Am Geriatr Soc 46: 978-982.
  20. Leibovitz E, Khanimov I, Wainstein J, Boaz M (2019) Documented hypoglycemia is associated with poor short and long term prognosis among patients admitted to general internal medicine departments. Diabetes Metab Syndr Clin Res Rev 13: 222-226.
  21. Nirantharakumar K, Marshall T, Hodson J, Narendran P, Deeks J, et al. (2012) Hypoglycemia in non-diabetic in-patients: Clinical or criminal? PLoS One 7: 40384.
  22. Toda G, Fujishiro M, Yamada T, Shojima N, Sakoda H, et al. (2014) Lung abscess without sepsis in a patient with diabetes with refractory episodes of spontaneous hypoglycemia: A case report and review of the literature. J Med Case Rep 8: 51.
  23. Nydick M, Samols E, Kuzuya T, Williams RH (1964) A difficult diagnostic problem in spontaneous hypoglycemia. Reactive hypoglycemia in mild diabetes mellitus. Ann intern med 61: 1122-1127.
  24. Conn JW, Fajans SS, Seltzer HS (1956) Spontaneous hypoglycemia as an early manifestation of diabetes mellitus. Diabetes 5: 437-442.
  25. Camilo ME (2003) Disease-related malnutrition: An evidence-based approach to treatment. Clinical Nutrition 22: 585.
  26. Gomez F, Galvan RR, Cravioto J, Frenk S (1955) Malnutrition in infancy and childhood, with special reference to kwashiorkor. Adv Pediatr 7: 131-169.
  27. Waterlow JC (1972) Classification and definition of protein-calorie malnutrition. Br Med J 3: 566-569.
  28. Grover Z, Ee LC (2009) Protein energy malnutrition. Pediatr Clin North Am 56: 1055-1068.
  29. Jensen GL, Bistrian B, Roubenoff R, Heimburger DC (2009) Malnutrition syndromes: A conundrum vs continuum. JPEN J Parenter Enteral Nutr 33: 710-716.
  30. Campbell IT (1999) Limitations of nutrient intake. The effect of stressors: Trauma, sepsis and multiple organ failure. Eur J Clin Nutr 1: 143-147.
  31. Saunders J, Smith T (2010) Malnutrition: Causes and consequences. Clin Med (Lond) 10: 624-627.
  32. McGuire S (2015) FAO, IFAD, and WFP. The State of Food Insecurity in the World 2015: Meeting the 2015 International Hunger Targets: Taking Stock of Uneven Progress. Rome: FAO, 2015. Adv Nutr 6: 623-624.
  33. Rasmussen HH, Holst M, Kondrup J (2010) Measuring nutritional risk in hospitals. Clin Epidemiol 2: 209-216.
  34. Giryes S, Leibovitz E, Matas Z, Fridman S, Gavish D, et al. (2012) MEasuring Nutrition risk in hospitalized patients: MENU, a hospital-based prevalence survey. Isr Med Assoc J 14: 405-409.
  35. Edington J, Boorman J, Durrant ER, Perkins A, Giffin CV, et al. (2000) Prevalence of malnutrition on admission to four hospitals in England. The Malnutrition Prevalence Group. Clin Nutr 19: 191-195.
  36. Correia MI, Campos AC, ELAN Cooperative Study (2003) Prevalence of hospital malnutrition in Latin America: The multicenter ELAN study. Nutrition 19: 823-825.
  37. Taksande A, Taksande B, Kumar A, Vilhekar KY, Taksande AM (2008) Malnutrition-related diabetes mellitus symposium on diabetes. J MGIMS 13: 19-24.
  38. Chattopadhyay PS, Gupta SK, Chattopadhyay R, Kundu PK, Chakraborti R (1995) Malnutrition-Related Diabetes Mellitus (MRDM), not diabetes-related malnutrition. A report on genuine MRDM. Diabetes Care 18: 276-277.
  39. Leibovitz E, Adler H, Giryes S, Ditch M, Burg NF, et al. (2018) Malnutrition risk is associated with hypoglycemia among general population admitted to internal medicine units. Results from the MENU study. Eur J Clin Nutr 72: 888-893.
  40. Rothschild MA, Oratz M, Schreiber SS (1973) Progress in gastroenterology albumin metabolism. Gastroenterology 64: 324-337.
  41. Lee JL, Oh ES, Lee RW, Finucane TE (2015) Serum albumin and prealbumin in calorically restricted, nondiseased individuals: A systematic review. Am J Med 128: 1023.
  42. Fanali G, di Masi A, Trezza V, Marino M, Fasano M, et al. (2012) Human serum albumin: From bench to bedside. Mol Aspects Med 33: 209-290.
  43. McCluskey A, Thomas AN, Bowles BJ, Kishen R (1996) The prognostic value of serial measurements of serum albumin concentration in patients admitted to an intensive care unit. Anaesthesia 51: 724-727.
  44. Numeroso F, Barilli AL, Delsignore R (2008) Prevalence and significance of hypoalbuminemia in an internal medicine department. Eur J Intern Med 19: 587-591.
  45. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM (2003) Hypoalbuminemia in acute illness: Is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 237: 319-334.
  46. Tormey WP, O’Brien PA (1993) Clinical associations of an increased transthyretin band in routine serum and urine protein electrophoresis. Ann Clin Biochem 30: 550-554.
  47. Beck FK, Rosenthal TC (2002) Prealbumin: A marker for nutritional evaluation. Am Fam Physician 65: 1575-1578.
  48. Mears E (1996) Outcomes of continuous process improvement of a nutritional care program incorporating serum prealbumin measurements. Nutrition 12: 479-484.
  49. Sullivan DH, Sun S, Walls RC (1999) Protein-energy undernutrition among elderly hospitalized patients: A prospective study. JAMA 281: 2013-2019.
  50. Sreedhara R, Avram MM, Blanco M, Batish R, Avram MM, et al. (1996) Prealbumin is the best nutritional predictor of survival in hemodialysis and peritoneal dialysis. Am J Kidney Dis 28: 937-942.
  51. Davis CJ, Sowa D, Keim KS, Kinnare K, Peterson S (2012) The use of prealbumin and C-reactive protein for monitoring nutrition support in adult patients receiving enteral nutrition in an urban medical center. J Parenter Enter Nutr 36: 197-204.
  52. Das S, Tripathy BB, Samal KC, Panda NC (1984) Plasma lipids and lipoprotein cholesterol in undernourished diabetic subjects and adults with protein energy malnutrition. Diabetes Care 7: 579-586.
  53. Zhang Z, Pereira S, Luo M, Matheson E (2017) Evaluation of blood biomarkers associated with risk of malnutrition in older adults: A systematic review and meta-analysis. Nutrients 9: 829.
  54. Leibovitz E, Wainstein J, Boaz M (2018) Association of albumin and cholesterol levels with incidence of hypoglycaemia in people admitted to general internal medicine units. Diabet Med 35: 1735-1741.
  55. Burda P, Hochuli M (2015) Hepatic glycogen storage disorders: What have we learned in recent years? Curr Opin Clin Nutr Metab Care 18: 415-421.

Citation: Khanimov I, Wainstein J, Shimonov M, Leibovitz E (2019) Malnutrition and Hypoglycemia Risk among Patients with Diabetes Mellitus. J Food Sci Nut: S1001.

Copyright: © 2019  Khanimov I, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Herald Scholarly Open Access is a leading, internationally publishing house in the fields of Sciences. Our mission is to provide an access to knowledge globally.

© 2023, Copyrights Herald Scholarly Open Access. All Rights Reserved!